Diacon®
  • Diacon®
  • Diacon®
  • Diacon®

Diacon®

Diabetes mellitus – Type – I and Type – II. By stimulating β cells of Pancreas to secrete insulin for sugar Metabolism

Image Combination Name Price Quantity
Pack of : 1
₹130.00
₹127.40
Save 2 %

In stock

Pack of : 2
₹260.00
₹247.00
Save 5 %

In stock

DIACON ®

(Anti-Diabetes)

100% Safe Homoeopathic preparation - No side effects


Diabetes mellitus – Type – I and Type – II. By stimulating β cells of the Pancreas to secrete insulin for sugar Metabolism. This cures Diabetes mellitus – Type – I and Type – II. Other symptoms of Diabetes mellitus that is relatively controlled with DEACON are e.g. Polydipsia, Polyuria, and Polyphagia.

PRESENTATION: 30 ml. Bottle with Cap & dropper.

ACTIVE INGREDIENTS (NATIVE/LATIN/ENGLISH NAME):

  1. ACID PHOS (PHOSPHORICUM ACIDUM)
  2. ACID NITRIC (NITRICUM ACIDUM )
  3. SYZYGIUM (SYZYGIUM JAMBOLANUM)
  4. URANIUM TRITICUM (NITRATE OF URANIUM) 

Contra-Indications: No known contra-indication.

Shelf life and special conditions for storage: Diacon is a Homoeopathic medicine, so it may be kept forever if It should be stored in a cool, dry place, should be properly & tightly caped, and protected from sunlight.

Dispensation:    Without prescription      - It may be used without prescription if the indication matches

                         With prescription             - It is recommended to use the medicine on prescription.

MUST CONSULT PHYSICIAN BEFORE USE.

INFORMATION FOR REGISTERED MEDICAL PRACTITIONERS/HOSPITALS/LABORATORIES.


Disclaimer:

The Food and Drug Administration has not evaluated the statements above and about this product. This product is not intended to diagnose, treat, cure or prevent any disease. The information on this Leaflet/brochure/Website or in emails is designed for educational purposes only. It is not intended as a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health problems or illnesses without consulting your physician or family doctor.

Comments (0)